Vor Biopharma
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $12,226 |
Gross Profit | -900 | -943 | 11,334 |
EBITDA | -29,035 | -31,383 | -27,232 |
EBIT | -29,935 | -31,426 | -28,124 |
Net Income | -27,839 | -30,804 | -26,261 |
Net Change In Cash | 0 | 0 | 12,226 |
Free Cash Flow | -21,856 | -30,579 | -24,137 |
Cash | 76,076 | 44,964 | 31,360 |
Basic Shares | 68,299 | 68,030 | 67,891 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -3,492 | -8,960 | -4,451 | -1,387 |
EBITDA | -114,371 | -90,893 | -67,584 | -41,950 |
EBIT | -117,863 | -99,853 | -72,035 | -43,337 |
Net Income | -117,863 | -90,770 | -68,780 | -43,337 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -62,095 | 72,116 | ||
Free Cash Flow | -101,361 | -93,606 | -73,038 | -40,453 |
Cash | 31,360 | 57,706 | 119,801 | 48,539 |
Basic Shares | 67,191 | 39,551 | 37,174 | 37,127 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.40 |
2024-06-30 | -$0.41 |
2024-03-31 | -$0.45 |
2023-12-31 | -$0.39 |
